Autologous serum eye drops versus lacrimal gland injection of platelet-rich plasma for severe dry eye
Author:
- 1 October 2021
- journal article
- research article
- Published by Medknow in Delta Journal of Ophthalmology
- Vol. 22 (4) , 251-258
Abstract
Aim: The aim of this study was to evaluate the use of autologous serum (AS) eye drops versus lacrimal gland injection of platelet-rich plasma (PRP) in the treatment of severe dry-eye disease (DED). Setting and design: This is a prospective comparative interventional study that was carried out at Eye Tech Centre, Alexandria, Egypt. Patients and methods: The study included 40 eyes of 20 patients with severe DED. They were randomized into two groups: group A received lacrimal gland injection of PRP transcutaneously into the external one-third of the orbital rim at a depth of 4 mm to the superior area on days 0, 30, 60, and 90, while group B received AS eye drops five times daily for the duration of the study. Both groups received preservative-free artificial tears eye drops (hyaluronic acid) —three to five times daily for the study duration. The patients were followed up for 12 weeks after the first injection or the initiation of AS eye drops for the subjective changes in symptoms and in ocular surface parameters. Results: The patients’ age ranged from 46 to 71 years (mean=56.0±8.2 years). Both groups showed a significant improvement of dry-eye symptoms (PPP0.05). The other ocular surface parameters, using the ocular surface analyzer, including the noninvasive tear breakup time, tear-meniscus height, and lipid-layer thickness, showed significant improvement in both groups (P0.05). Conclusions: Both AS and lacrimal gland injection of PRP proved the safety and efficacy in the treatment of severe DED and were comparable. More studies are needed to confirm these results.Keywords
This publication has 25 references indexed in Scilit:
- TFOS DEWS II Report Executive SummaryThe Ocular Surface, 2017
- TFOS DEWS II Management and Therapy ReportThe Ocular Surface, 2017
- TFOS DEWS II Definition and Classification ReportThe Ocular Surface, 2017
- Visual acuity and quality of life in dry eye disease: Proceedings of the OCEAN group meetingThe Ocular Surface, 2017
- PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory modelExperimental Eye Research, 2016
- The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover studyGraefe's Archive for Clinical and Experimental Ophthalmology, 2014
- An optimised protocol for the production of autologous serum eyedropsGraefe's Archive for Clinical and Experimental Ophthalmology, 2005
- The effect of autologous serum eyedrops in the treatment of severe dry eye disease: A prospective randomized case-control studyAmerican Journal of Ophthalmology, 2005
- Diagnosis of Dry EyeSurvey of Ophthalmology, 2001
- Beneficial Effect of Artificial Tears Made with Autologous Serum in Patients with Keratoconjunctivitis SiccaArthritis & Rheumatism, 1984